17. 多系統萎縮症 Multiple system atrophy Clinical trials / Disease details
臨床試験数 : 119 / 薬物数 : 138 - (DrugBank : 44) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 111
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04165486 (ClinicalTrials.gov) | July 21, 2022 | 14/11/2019 | Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adults With Multiple System Atrophy (HORIZON) | A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of ION464 Administered Intrathecally to Adults With Multiple System Atrophy | Multiple System Atrophy | Drug: ION464;Drug: Placebo | Ionis Pharmaceuticals, Inc. | NULL | Recruiting | 40 Years | 70 Years | All | 40 | Phase 1 | Austria;France;Germany;United Kingdom;Portugal |